| PERIOD ENDING | 27-Dec-09 | 27-Sep-09 | 28-Jun-09 | 29-Mar-09 | | Total Revenue | 2,670,000 | 2,690,000 | 2,754,000 | 2,455,000 | | Cost of Revenue | 816,000 | 824,000 | 864,000 | 738,000 | | | Gross Profit | 1,854,000 | 1,866,000 | 1,890,000 | 1,717,000 | | | Operating Expenses | | Research Development | 596,000 | 614,000 | 619,000 | 603,000 | | Selling General and Administrative | 379,000 | 621,000 | 376,000 | 376,000 | | Non Recurring |
-
| 35,000 |
-
| 748,000 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 879,000 | 596,000 | 895,000 | (10,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 146,000 | 89,000 | (91,000) | | Earnings Before Interest And Taxes | 1,052,000 | 742,000 | 984,000 | (101,000) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 1,052,000 | 742,000 | 984,000 | (101,000) | | Income Tax Expense | 211,000 | (60,000) | 246,000 | 188,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 841,000 | 802,000 | 738,000 | (289,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 841,000 | 802,000 | 738,000 | (289,000) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $841,000 | $802,000 | $738,000 | ($289,000) |
|
1.52% Nasdaq 
Income Statement
